By Drug Target Review2024-01-03T12:00:03
For diseases mediated by NLRP3, AIM2, NLRC4, and Pyrin, understanding inflammasome biology could identify therapeutic targets.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-18T14:47:08Z
2025-08-05T13:42:00
Sponsored by ICON plc., By Drug Target Review
2024-01-26T13:22:42
Sponsored by bit.bio
2023-02-13T11:57:11
Sponsored by Agilent
2023-04-04T15:03:09
Sponsored by Agilent
2024-05-10T11:23:31
Sponsored by BellBrook Labs
2023-07-11T16:13:06
Sponsored by Agilent
Site powered by Webvision Cloud